Third Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies

Hogan Lovells is a sponsor of the Third Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies, which will provide expert advice on how to manage the potential fallout from these disclosures as well as on the myriad operational questions that companies are now confronting. In-house experts will offer first-hand advice on a wide array of emerging best practices ranging from project management to building scalability and sustainability. Panels of outside experts and third parties will examine various aggregate spend technology solutions. The Summit will also feature senior regulators from the HHS Office of Inspector General (OIG) and other agencies, as well as former Justice Department attorneys, on how the government is likely to use these data.

For more information about this event, including details on registration, please visit the event website.

Attendees wishing to register through Hogan Lovells will receive a discounted registration rate. For onsite attendance $995; online attendance $595. To receive this discount, visit the event registration page and enter the code "device" at the bottom of the form. 


Back To Listing
Loading data